PWM
Palumbo Wealth Management Portfolio holdings
AUM
$323M
This Quarter Return
+1.21%
1 Year Return
+22.5%
3 Year Return
+55.87%
5 Year Return
–
10 Year Return
–
AUM
$299M
AUM Growth
+$299M
(+12%)
Cap. Flow
+$31.9M
Cap. Flow
% of AUM
10.65%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
199
New
24
Increased
127
Reduced
28
Closed
12
Top Buys
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$2.05M |
| 2 |
Apple
AAPL
|
$1.63M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$1.53M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$1.45M |
| 5 |
NVIDIA
NVDA
|
$1.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$3.62M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$1.22M |
| 3 |
GeneDx Holdings
WGS
|
$638K |
| 4 |
CrowdStrike
CRWD
|
$407K |
| 5 |
ServiceNow
NOW
|
$296K |
Sector Composition
| 1 | Technology | 15.17% |
| 2 | Healthcare | 8.12% |
| 3 | Financials | 7.99% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Industrials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
MindMed
MNMD
$676M
| $132K | 0.04% | +22,628 | New | +$132K |
|
177
QuantumScape
QS
$4.49B
| $131K | 0.04% | +31,456 | New | +$131K |
|
178
Cullinan Oncology
CGEM
$445M
| $123K | 0.04% | +16,268 | New | +$123K |
|
179
Assertio
ASRT
$80.4M
| $115K | 0.04% | 171,176 -34,422 | -17% | -$23.2K |
|
|
BWAY
180
Brainsway
BWAY
$294M
| $111K | 0.04% | +11,773 | New | +$111K |
|
|
GRCE
181
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
| $105K | 0.04% | +46,007 | New | +$105K |
|
|
VERV
182
DELISTED
Verve Therapeutics
VERV
| $72.4K | 0.02% | +15,845 | New | +$72.4K |
|
|
ELEV
183
DELISTED
Elevation Oncology
ELEV
| $72K | 0.02% | 278,002 +208,897 | +302% | +$54.1K |
|
184
Erasca
ERAS
$445M
| $59.4K | 0.02% | 43,331 +14,731 | +52% | +$20.2K |
|
185
Nautilus Biotechnolgy
NAUT
$85.9M
| $35.4K | 0.01% | 41,162 +12,687 | +45% | +$10.9K |
|
186
Ventyx Biosciences
VTYX
$171M
| $30.5K | 0.01% | 26,498 +2,566 | +11% | +$2.95K |
|
|
INZY
187
DELISTED
Inozyme Pharma
INZY
| $27.1K | 0.01% | 29,784 +6,503 | +28% | +$5.92K |
|
188
ProShares Ultra NASDAQ Biotechnology
BIB
$53.6M
| – | – | -4,000 | Closed | -$203K |
|
189
Credo Technology Group
CRDO
$21.3B
| – | – | -3,832 | Closed | -$258K |
|
190
Criteo
CRTO
$1.3B
| – | – | -5,264 | Closed | -$208K |
|
191
Ginkgo Bioworks
DNA
$750M
| – | – | -14,631 | Closed | -$144K |
|
192
FedEx
FDX
$54.5B
| – | – | -754 | Closed | -$212K |
|
193
OmniAb
OABI
$230M
| – | – | -21,204 | Closed | -$75.1K |
|
194
Ocular Therapeutix
OCUL
$2.12B
| – | – | -11,693 | Closed | -$99.9K |
|
|
195
GeneDx Holdings
WGS
$3.72B
| – | – | -8,303 | Closed | -$638K |
|
|
FNA
196
DELISTED
Paragon 28, Inc.
FNA
| – | – | -16,553 | Closed | -$171K |
|
|
INFN
197
DELISTED
Infinera Corporation Common Stock
INFN
| – | – | -33,883 | Closed | -$223K |
|
|
MTTR
198
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| – | – | -26,073 | Closed | -$124K |
|
|
ZUO
199
DELISTED
Zuora, Inc.
ZUO
| – | – | -16,152 | Closed | -$160K |
|